Reprogramming to iPS cells and their subsequent hematopoietic differentiation is more efficient from MEFs than from preB cells

Immunology Letters

Volumn 143, Issue 1, 2012, Pages 70-76

  Reimer, Andreas ^a   Seiler, Katharina ^a,b   Tornack, Julia ^a   Tsuneto, Motokazu ^a   Melchers, Fritz ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

In vitro hematopoiesis; IPS; MEF; PreB cells; Reprogramming

Indexed keywords

KRUPPEL LIKE FACTOR 4; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; FETUS; FETUS LIVER; FIBROBLAST; HEMATOPOIESIS; HEMATOPOIETIC CELL; IN VITRO STUDY; LYMPHOPOIESIS; MESODERM; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; B-LYMPHOCYTES; BLOOD CELLS; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; FIBROBLASTS; INDUCED PLURIPOTENT STEM CELLS; KINETICS; MICE; NUCLEAR REPROGRAMMING;

EID: 84858863039     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2012.01.012     Document Type: Article

References (19)

1. Lowry W.E., Plath K. The many ways to make an iPS cell. Nat Biotechnol 2008, 11:1246-1248.
2. Aoi T., Yae K., Nakagawa M., Ichisaka T., Okita K., Takahashi K., et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 2008, 321:699-702.
3. Park I.H., Zhao R., West J.A., Yabuuchi A., Huo H., Ince T.A., et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2007, 451:141-147.
4. Stadtfeld M., Brennand K., Hochedlinger K. Reprogramming of pancreatic b cells into induced pluripotent stem cells. Curr Biol 2008, 18:890-894.
5. Nakagawa M., Koyanagi M., Tanabe K., Takahashi K., Ichisaka T., Aoi T., et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 2008, 26:101-106.
6. Eminli S., Foudi A., Stadtfeld M., Maherali N., Ahfeldt T., Mostoslavsky G., et al. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat Genet 2009, 41:968-978.
7. Hanna J., Markoulaki S., Schorderet P., Carey B.W., Beard C., Wernig M., et al. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 2008, 133:250-264.
8. Lin T., Ambasudhan R., Yuan X., Li W., Hilcove S., Abujarour R., et al. A chemical platform for improved induction of human iPSCs. Nat Biotechnol 2009, 6:805-809.
9. Mikkelsen T.S., Hanna J., Zhang X., Ku M., Wernig M., Schorderet P., et al. Dissecting direct reprogramming through integrative genomic analysis. Nature 2008, 454:49-56.
10. Brambrink T., Foreman R., Welstead G.G., Lengner C.J., Wernig M., Suh H., et al. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Stem Cell 2008, 151-159.
11. Kim K., Doi A., Wen B., Ng K., Zhao R., Kim J., et al. Epigenetic memory in induced pluripotent stem cells. Nature 2008; 2008, 467:285-292.
12. Maherali N., Sridharan R., Xie W., Utikal J., Eminli S., Arnold K., et al. Direct reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Stem Cell 2007, 1:55-70.
13. Hu B.Y., Weick J.P., Yu J., Ma L.X., Zhang X.Q., Thomson J.A., et al. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Nat Acad Sci USA 2010, 107:4335-4340.
14. Choi K.D., Yu J., Smuga-Otto K., Salvagiotto G., Rehrauer W., Vodyanik M., et al. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 1992, 27:559-567.
15. Sommer C.A., Sommer A.G., Longmire T.A., Christodoulou C., Thomas D.D., Gostissa M., et al. Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector. Stem Cell 1992, 28:64-74.
16. Seiler K., Noghabi M.S., Karjalainen K., Hummel M., Melchers F., Tsuneto M. Induced pluripotent stem cells expressing elevated levels of Sox-2, Oct-4 and Klf-4 are severely reduced in their differentiation from mesodermal to hematopoietic progenitor cells. Stem Cell Dev 2011, 20:1-12.
17. Tsuneto M., Yamane T., Okuyama H., Yamazaki H., Hayashi S. In vitro differentiation of mouse ES cells into hematopoietic, endothelial, and osteoblastic cell lineages: the possibility of in vitro organogenesis. Methods Enzymol 2003, 365:98-114.
18. Melchers F. B lymphocyte development in fetal liver. Eur J Immunol 1977, 7:476-481.
19. Rolink A., Kudo A., Karasuyama H., Kikuchi Y., Melchers F. Long-term proliferating early pre B cell lines and clones with the potential to develop to surface Ig-positive, mitogen reactive B cells in vitro and in vivo. EMBO J 1991, 10:327-336.